Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
BT-20
TNBC
Basal A
Imatinib
ABL/KIT/PDGFR
nRTK
5903.09
uM
14.23390
26.11670
-0.9964 -1.0000 1.8101 0.5188
0.9862
0.9291
600MPE
HR+
Luminal
Bromopyruvic acid
Hexokinase II
Metabolism
13091.177
uM
0.13548
0.2280
-1.0000 -1.0000 2.1106 0.8509
0.9450
0.7004
BT-20
TNBC
Basal A
AS-252424
PI3K
PI3K
11854.158
uM
24.60350
145.14930
0.2089 -1.0000 0.6190 0.1259
0.9644
1.3776
AU565
HER2amp
Luminal
17-AAG
HSP90
HSP90
9146.037
uM
0.15634
3.69020
-0.9186 -1.0000 0.3475 0.5819
0.8060
1.2617
BT-20
TNBC
Basal A
Imatinib
ABL/KIT/PDGFR
nRTK
5904.092
uM
7.68060
18.45430
-0.9954 -1.0000 1.2533 0.6283
0.9466
0.8933
BT-474
HER2amp
Luminal
Carboplatin
DNA cross-linker
DNA cross-linker
9163.011
uM
92.88920
177.40340
-0.9636 -1.0000 1.6980 0.2967
0.9963
0.6266
600MPE
HR+
Luminal
Mebendazole
13091.174
uM
14.64610
480.70650
0.3243 -1.0000 0.3147 0.2245
0.8786
0.7967
BT-20
TNBC
Basal A
FR180204
ERK1/2
MAPK
11854.161
uM
100.53860
466.86010
0.4990 -1.0000 0.7155 0.1017
0.7789
1.2085
600MPE
HR+
Luminal
Nutlin 3a
MDM2
MDM2
5899.066
uM
42.47440
128.71880
0.2966 -1.0000 0.9909 0.1530
0.6806
0.7056
600MPE
HR+
Luminal
5-FU
TYMS
TYMS
9118.017
uM
78.35630
305.35030
-0.9327 -1.0000 0.8077 0.6926
0.9801
1.0401
600MPE
HR+
Luminal
Afatinib
EGFR/HER2
ErbB
12224.165
uM
2.4860
3.88950
-0.9804 -1.0000 2.4546 0.6104
0.9030
0.9714
184A1
NM
Basal
Etoposide
TOP2
TOP
5894.074
uM
9.28560
35.69030
-0.7680 -1.0000 0.8160 0.4044
0.9826
1.4541
600MPE
HR+
Luminal
Fascaplysin
CDK4
CDK
5898.085
uM
0.26595
0.36220
-0.9980 -1.0000 3.5567 0.7703
0.9784
0.7048
184B5
NM
Basal
Bromopyruvic acid
Hexokinase II
Metabolism
12979.177
uM
0.02740
0.03413
-1.0000 -1.0000 5.0000 1.0789
0.9988
0.5647
600MPE
HR+
Luminal
AG1478
EGFR
ErbB
7791.016
uM
34.63250
70.58790
-0.6402 -1.0000 1.5428 0.2456
0.8929
0.8138
600MPE
HR+
Luminal
AS-252424
PI3K
PI3K
12224.165
uM
8.75170
136.14630
0.2719 -1.0000 0.4003 0.2034
0.8983
0.9714
BT-474
HER2amp
Luminal
CGC-11047
Polyamine analogue
9163.026
uM
1.16670
17.90580
-1.0000 -1.0000 0.4023 0.8897
0.9004
0.3738
AU565
HER2amp
Luminal
Everolimus
MTOR
MTOR
10880.156
uM
0.57383
7.51240
-0.8788 -1.0000 0.4272 0.4508
0.8269
1.5288
600MPE
HR+
Luminal
Bortezomib
Proteasome
Proteasome
5898.074
uM
1.85990
6.61990
-0.8905 -1.0000 0.8654 0.5349
0.9882
0.7134
600MPE
HR+
Luminal
Bortezomib
Proteasome
Proteasome
5898.074
uM
1.85990
6.61990
-0.8905 -1.0000 0.8654 0.5349
0.9882
0.7134
184A1
NM
Basal
Etoposide
TOP2
TOP
5895.074
uM
10.48650
42.19930
-0.7395 -1.0000 0.7891 0.3710
0.9859
1.1218
184B5
NM
Basal
Chloroquine
12979.177
uM
19.64650
24.47430
-1.0000 -1.0000 5.0000 0.1512
0.9526
0.5647
600MPE
HR+
Luminal
Ixabepilone
TUBB
TUBB
5898.095
uM
0.05465
2.31930
-0.9967 -1.0000 0.2931 0.5721
0.6309
0.6975
HCC1143
TNBC
Basal A
CPT-11
TOP1
TOP
9233.121
uM
17.63230
78.47640
-0.0443 -1.0000 0.7358 0.1290
0.9627
0.9468
HCC1143
TNBC
Basal A
CGC-11047
Polyamine analogue
7810.006
uM
69.91230
288.45370
-0.9802 -1.0000 0.7752 0.5465
0.8937
0.9730